Literature DB >> 18835720

Anti-inflammatory properties of a heparin-like glycosaminoglycan with reduced anti-coagulant activity isolated from a marine shrimp.

Adriana S Brito1, Dayse S Arimatéia, Lucilla R Souza, Marcelo A Lima, Vanessa O Santos, Valquíria P Medeiros, Paula A Ferreira, Rodrigo A Silva, Carmen V Ferreira, Giselle Z Justo, Edda L Leite, Giulianna P V Andrade, Fernanda W Oliveira, Helena B Nader, Suely F Chavante.   

Abstract

The anti-inflammatory properties of a heparin-like compound from the shrimp Litopenaeus vannamei are related. Besides reducing significantly (p<0.001) the influx of inflammatory cells to injury site in a model of acute inflammation, shrimp heparin-like compound was able to reduce the matrix metalloproteinase (MMPs) activity in the peritoneal lavage of inflamed animals. Moreover, this compound also reduced almost 90% the activity of MMP-9 secreted by human activated leukocytes. Negligible anti-coagulant activities in aPPT assay and a poor bleeding potential make this compound a better alternative than mammalian heparin as a possible anti-inflammatory drug.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835720     DOI: 10.1016/j.bmc.2008.09.020

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  A peptide found by phage display discriminates a specific structure of a trisaccharide in heparin.

Authors:  Tomio Yabe; Ritsuko Hosoda-Yabe; Yoshihiro Kanamaru; Makoto Kiso
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

2.  New anti-angiogenic compound based on chemically modified heparin.

Authors:  Vinicius Kniggendorf; Maria Eduarda Perrud Souza; Thatiane Russo; Marcelo Andrade de Lima; Alex Treiger Grupenmacher; Caio V Regatieri; Juliana L Dreyfuss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-13       Impact factor: 3.535

Review 3.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

4.  Metalloproteinase inhibitors: status and scope from marine organisms.

Authors:  Noel Vinay Thomas; Se-Kwon Kim
Journal:  Biochem Res Int       Date:  2010-12-09

5.  Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects.

Authors:  Sergey N Fedorov; Svetlana P Ermakova; Tatyana N Zvyagintseva; Valentin A Stonik
Journal:  Mar Drugs       Date:  2013-12-02       Impact factor: 5.118

6.  RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues.

Authors:  Jasper J van Gemst; Markus A Loeven; Mark J J de Graaf; Jo H M Berden; Ton J Rabelink; Cornelis H Smit; Johan van der Vlag
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

Review 7.  Marine Carbohydrate-Based Compounds with Medicinal Properties.

Authors:  Ariana A Vasconcelos; Vitor H Pomin
Journal:  Mar Drugs       Date:  2018-07-09       Impact factor: 5.118

8.  Extraction, Characterization, and Anticoagulant Activity of a Sulfated Polysaccharide from Bursatella leachii Viscera.

Authors:  Manel Dhahri; Salim Sioud; Rihab Dridi; Mohsen Hassine; Naceur A Boughattas; Fatimah Almulhim; Zeyad Al Talla; Mariusz Jaremko; Abdul-Hamid M Emwas
Journal:  ACS Omega       Date:  2020-06-10

9.  Evaluation of anti-nociceptive and anti-inflammatory activities of a heterofucan from Dictyota menstrualis.

Authors:  Ivan Rui Lopes Albuquerque; Sara Lima Cordeiro; Dayanne Lopes Gomes; Juliana Luporini Dreyfuss; Luciana Guimarães Alves Filgueira; Edda Lisboa Leite; Helena Bonciani Nader; Hugo Alexandre Oliveira Rocha
Journal:  Mar Drugs       Date:  2013-08-02       Impact factor: 5.118

10.  Isolation and Characterization of a Heparin-Like Compound with Potent Anticoagulant and Fibrinolytic Activity from the Clam Coelomactra antiquata.

Authors:  ZhenXing Du; XueJing Jia; Jing Chen; SiYi Zhou; JianPing Chen; XiaoFei Liu; XiaoHuang Cao; SaiYi Zhong; PengZhi Hong
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.